Literature DB >> 29671293

Surgical treatment for refractory epilepsy.

Johannes Herta1, Christian Dorfer2.   

Abstract

The goal of any epilepsy surgery is to improve patient's quality of life by achieving seizure freedom or by reducing the frequency of severely debilitating seizures. To achieve this goal, non-invasive and invasive diagnostic methods must precisely delineate the epileptogenic zone (EZ), which is defined as the area that needs to be resected to obtain seizure freedom. At the same time, the correct identification of eloquent brain areas is inevitable to avoid new neurological deficits from surgery. In recent years, the technical advances in diagnostics have enabled us to achieve these goals in an increasing number of cases. As a consequence, and with new surgical treatment options available, the number of patients who might benefit from epilepsy surgery is constantly increasing. Especially in pediatric epilepsy, early surgical intervention is becoming frequently advocated as it has been shown to improve cognitive and behavioral outcome. Specialized epilepsy centers and multidisciplinary teams are required to provide adequate care and treatment. The goal of this review is to describe important diseases that are accessible to epilepsy surgery and to give an overview of current diagnostic methods. The focus lies on established as well as novel techniques in epilepsy surgery. The presurgical work-up and patient selection is outlined.

Entities:  

Mesh:

Year:  2018        PMID: 29671293     DOI: 10.23736/S0390-5616.18.04448-X

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  3 in total

1.  Screening of Risk Factors for Poor Prognosis in Patients with Refractory Epilepsy Secondary to Encephalomalacia.

Authors:  Yinjun Zhong
Journal:  Comput Math Methods Med       Date:  2022-07-04       Impact factor: 2.809

2.  Early Prediction of Refractory Epilepsy in Children Under Artificial Intelligence Neural Network.

Authors:  Yueyan Huang; Qingfeng Li; Qian Yang; Zhijing Huang; Hongbo Gao; Yunan Xu; Lianghua Liao
Journal:  Front Neurorobot       Date:  2021-06-17       Impact factor: 2.650

3.  microRNA-139-5p confers sensitivity to antiepileptic drugs in refractory epilepsy by inhibition of MRP1.

Authors:  Li Wang; Lifang Song; Xiaoyi Chen; Junfang Suo; Yanli Ma; Jinghe Shi; Kai Liu; Guohong Chen
Journal:  CNS Neurosci Ther       Date:  2019-11-21       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.